MERCK Stock Quote
$60.52 
Change:
-1.50 %Chge:
-2.42% Vol:
968,916
End Of Day Prices
High: 61.9 | Low: 60.52 | Open: 61.54 | Close: 60.52
52 Wk High: 63.62 | 52 Wk Low: 51.945 | Todays Pivot: 60.98
Sector: Healthcare and Pharmaceuticals
Merck Company Profile
Merck & Co (MRK) is a global pharmaceutical giant that manufactures key health products for human and animal health. They are the second largest company worldwide, as measured by market share. Grossing over $27 billion dollars annually, Merck are well known for producing leading scientific research and powerful pharmaceutical products. Since merging with Schering-Plough in 2009, the company has combined product lines for what they term is a “stronger pipeline”
» Read More About Merck
MRK Chart
You need Flash Player to see the chart, please download from the link below
Related Healthcare and Pharmaceuticals Companies
Above is a small selection of related companies to Merck which compete alongside MRK within the Healthcare and Pharmaceuticals sector.
Online News For Merck
|
Pro-Life Groups say Merck is Partly to Blame for Measles Outbreaks - Wall Street Journal (blog)
Fri, 30 Jan 2015 18:43As the measles outbreak focuses attention on parents who object to vaccination, some pro-life groups argue one culprit contributing to the problem is actually Merck, which makes the only measles vaccine available in the U.S. And some have begun a new ...
|
|
Merck KGaA abandons Symphogen's cancer drug ahead of Phase III - FierceBiotech
Thu, 29 Jan 2015 13:56Merck KGaA, in the process of paring down its pipeline, is walking away from a $625 million deal with Symphogen and handing back the company's lead asset, a targeted cancer treatment in midstage trials. Both companies said the decision is in no way a ...
|
|
Top-Selling Vaccine Made Cheap Shows Challenge to Merck: Health - Bloomberg
Mon, 26 Jan 2015 16:21The presence of low-cost alternatives to Merck and Glaxo's vaccine may encourage developing countries to add HPV immunization to their routine schedules, creating a bigger market for all the manufacturers and eventually benefitting Merck and Glaxo ...
|
|
Merck Selects CRedit360's Sustainability Management Software - Environmental Leader
Fri, 30 Jan 2015 12:54Pharmaceutical and chemical company Merck has chosen CRedit360's software to help improve the consistency of its global sustainability data management and reporting. The German based company, which employs around 39,000 people in 66 countries, ...
|
|
Merck Will No Longer Sell its Victrelis Hepatitis C Drug in the US - Wall Street Journal (blog)
Wed, 21 Jan 2015 16:02Rival hepatitis C drugs from Merck and Vertex Pharmaceuticals VRTX -1.99% made a big splash when they debuted in 2011, marking an advance in treatment of the liver disease and a lucrative new market segment. But now the Class of 2011 has almost ...
|
|
Merck's Fake MMR Trial Results Buried Even As Measles Scare Shows Vaccine ... - News Every day
Mon, 26 Jan 2015 14:42In 2010, two Merck scientists filed a False Claims Act complaint that was unsealed three years ago. The vaccine manufacturer, Merck, falsified its mumps vaccine test data even though it was aware of it. It "spiked blood samples with animal antibodies ...
|
Want To Add This Quote To Your Site?
With our stock widgets you can add a Merck quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for MRK to choose from. Visit here to build your stock quote widget »
